1. The intestinal absorption of carnosine, glycylglycine, glycyl-D-phenylalanine, glycyl-L-phenylalanine, glycyl-L-proline and L-prolylglycine were investigated after intraluminal injection of dipeptide into anaesthetized rats.
liver and elsewhere so that changes in peptide and amino acid concentrations in peripheral blood do not accurately reflect their absorption. Despite these complications, the intact absorption of peptides into the circulation has been reported for glycylglycine (Newey & Smyth, 1959; Peters & MacMahon, 1970; Adibi, 1971) , carnosine (Perry, Hansen, Tischler, Bunting & Berry, 1967) and prolylhydroxyproline (Hueckel & Rogers, 1972) .
An alternative to the sampling of peripheral blood is the sampling of mesenteric blood, but even this technique can be unsatisfactory. First, hydrolysis of peptides proceeds rapidly, and secondly, it is difficult to sample mesenteric or portal blood. In the work described here, we have surmounted the first of these problems by injection of high concentrations of dipeptide into the lumen of the small intestine. The second was overcome by collecting samples of blood from the superior mesenteric vein of rats, before the peptides had reached the systemic circulation and had been subjected to enzymic hydrolysis by the liver and other tissues. This technique, devised by one of us (D.P.) has been described in detail elsewhere (Butterworth & Pelling, 1973) . Using this method we have been able to detect intact dipeptide in the mesenteric venous blood in the case of every compound examined.
METHODS

Peptide hydrolase activity
The ability of mucosa from the rat small intestine to hydrolyse a series of dipeptides was assessed by a modification of the qualitative screening test described by Heizer & Laster (1969) .
Male Charles River rats (450-600 g) were starved overnight and killed by a blow on the head. The entire small intestine was removed, flushed with sucrose solution (250 mmol/l) at 4°C and the mucosa then scraped off with a scalpel blade. The mucosa was weighed, suspended in sucrose solution (250 mmol/l; 5 ml/g wet wt.) and disrupted by ultrasound using an MSE 150 W ultrasonic disintegrator (Measuring and Scientific Equipment Ltd, Crawley, Sussex), fitted with a titanium exponential microprobe tip. Ultrasonic impulses were applied to the tissue, kept at 4"C, at the rate of 20 MHz in intermittent bursts for a total time of 60 s. The disintegrator settings used were 'low' and 'I' and under these conditions the current strength did not exceed 8 pA.
This suspension was used for assay except when pilot experiments had indicated the hydrolase activity was greater than 20 pmol g-' 10 min-' (weight as wet tissue). In such cases, the tissue solution was diluted 1/10 with sucrose (250 mmol/l).
Peptide solutions (20 mmol/l) were prepared in Tris-maleate buffer (200 mmol/l; pH 7.5). After being warmed, 100 pl of this buffer-substrate solution was mixed with 100 pl of tissue solution and incubated at 37°C for 10 min. A portion (50 p1) was then removed from the incubation mixture and added to sulphosalicylic acid solution (200 g/l). Distilled water (2 ml) was added to the sample before assay by ion-exchange chromatography. Pure peptide solutions and sonified tissue extract without added peptide were used as controls and blanks respectively.
Boiled tissue and tissue precipitated with equal volumes of sulphosalicylic acid solution (200 g/l) were also examined for peptide hydrolase activity. Hydrolase activity was expressed as mol of peptide hydrolysed/g wet wt. of mucosa during the 10 min incubation (pmol g-' 10 min-') and an arbitrary value relative to the highest activity (100) assigned to each peptide.
Absorption in vivo
Male Charles River rats of 350-600 g body weight were starved overnight and anaesthetized with ether followed by pentobarbitone sodium (40 mg/kg intravenously). The right external jugular vein was cannulated with polyethylene tubing (PP 100, Portland Plastics Ltd). The abdomen was opened by mid-line incision and the superior mesenteric vein exposed by carefully parting the fatty tissue overlying it. The drawn and bevelled tip of a length of PP 100 tubing was inserted into a hole cut in the vein. The blood flow was interrupted for 1-2 min during insertion of this cannula which conveyed the portal blood to the jugular vein. The cannula was inserted into the superior mesenteric vein below the splenic and pyloric tributaries. Thus blood was collected from a loop 40-60 cm in length composed of jejunum and ileum, and extending to within 5 cm of the ileo-caecal junction. Branches draining the gut distal to the ileo-caecal junction were tied off.
The blood pressure and flow in the mesenteric-central venous shunt were recorded continuously by means of a pressure transducer, drop counter and recorder (Devices Ltd). The shunt was primed with heparinized sodium chloride solution (150 mmol/l) and had a total volume of 0-5 ml. Short plugged lengths of PP 100 tubing were tied into each end of the ileal loop drained by the shunt. The ileum remained in situ throughout the procedure; manipulation of the intestine was necessary only at the two ends of the loop to insert the luminal cannulae and to inject the test substance. After establishing the shunt the abdomen was closed with Michel clips, leaving space for exit of the cannulae and for a thermometer placed in the peritoneal cavity. At least 15 min were allowed for restoration of normal temperature before taking control blood samples from the shunt. Further details are given in the original description of this procedure (Butterworth & Pelling, 1973) .
Samples (4O-400 pl) of mesenteric and jugular venous blood were taken from respective ends of the shunt, before and at intervals after introducing 1.5 ml of peptide solution into the lumen. The peptides (100 mmol/l, unless otherwise stated) were dissolved in sodium chloride solution (150 mmol/l). After injection, the mesenteric blood was sampled for 30 min in at least two experiments and for 60 min in at least one experiment with each peptide. The samples were kept in an ice bath for not more than 20 min and then centrifuged at 3000 g. The plasma was removed and mixed with 3 volume of sulphosalicylic acid solution (200 g/l) and diluted to 2-3 ml for assay.
Materials and analytical techniques
The
L-prolylglycine (L-Pro-Gly) were obtained from Calbiochem Ltd and the Sigma Chemical Co. and were found to be chromatographically pure. Amino acid analysis was performed using a JLC-5AH automatic analyser [Japan Electron Optics (U.K.) Ltd], solutions of relevant amino acids and peptides being assayed as required as external standards. For the assay of peptide hydrolase activity, analytical programmes were designed to measure one of the amino acid products of the peptide hydrolysis. For the analysis of peptides and amino acids in plasma collected during the experiments in vivo, programmes were designed to measure plasma concentration of the dipeptide in question, its constituent amino acids and L-alanine. In three pilot experiments, peptides were added to plasma before precipitation of protein and subsequent analysis. Assay values of not less than 97% of the theoretical value were obtained.
R E S U L T S
Peptide hydrolase activity
As we did not investigate the kinetics of dipeptide hydrolysis in detail, the quantitative aspects of our results must be interpreted with caution. Nevertheless, under the experimental conditions used, it is possible to obtain a qualitative picture of the range of enzyme activity of the mucosa towards the peptides studied. The range of activity was over 300-fold; Gly-L-Phe being hydrolysed the most, and carnosine the least. The maximum variation between rats for any one peptide was fourfold (Gly-L-Phe) but the mean variation was considerably less as indicated by the SD values shown in Table 1 .
No hydrolytic activity was seen in any of the control procedures described in the Methods section.
Absorption of dipeptides and amino acids in vivo
Time-course of absorption. After intraluminal injection, the dipeptide or its constituent amino acids appeared in the superior mesenteric circulation. Intact dipeptides were detected in most experiments and amino acid concentrations were invariably increased. In all except one of the fifteen time-course experiments, maximum peptide concentration occurred within 30 min. Peak concentrations of amino acids were noted between 5 min and 60 min, which was the longest time investigated. There was no obvious relationship between peptide structure and the time of appearance of peak concentrations.
Figs. 1 and 2 present results from individual experiments showing changes in plasma peptide concentrations with time. Each graph on Fig. 1 and Fig. 2 represents data from a single animal. The cumulated data are presented in Table 1 , which shows that there were wide individual variations in plasma concentrations.
Figs. l(a) and l(b) show examples of changes in plasma peptide concentrations with time for five of the six compounds investigated. Fig. 2 shows examples of changes in plasma peptide and amino acid concentration with time, using one experiment with Gly-L-Phe as an example. Generally the increase in plasma concentration was substantially greater for amino acids than for peptides.
Relationship between peptide hydrolysis and detection of intact peptide. Table 1 shows the results of all experiments in which mesenteric plasma was sampled 15 min after peptide injection. These data are compared with information on the rate of hydrolysis of dipeptides under standard conditions, the peptides being arranged in decreasing order of hydrolysis.
We found that the two peptides which were most rapidly hydrolysed, Gly-L-Phe and Gly-L-Pro (Table l) , were detected in two out of four and three out of four experiments; all others, whose hydrolysis rate was at least an order of magnitude less, were detected in every instance (four out of four or five out of five experiments). Further experiments would be required to establish the precise relationship between incidence of detection and hydrolysis rate.
Peptide and amino acid concentrations in mesenteric venous plasma
Quantitative comparisons of the relationship between peptide and amino acid concentrations after injection of different peptides were possible. However, due to experimental variations in time of appearance of peak concentrations in the plasma, it was necessary to treat the data with caution. The qualitative picture that emerged showed that increases in plasma peptide concentrations were inversely related to the rate of peptide hydrolysis (Table l) , whereas no such relationship exists for the component amino acids. It can be seen that with Gly-L-Phe, Gly-L-Pro, L-Pro-Gly the increase in plasma concentration of the N-terminal component amino acid was similar to the increase of the C-terminal amino acid. This was not the case with Gly-D-Phe; with carnosine the N-terminal amino acid was not studied. Table 1 illustrates the increases in plasma peptide and amino acid concentration 15 min after intraluminal injection of peptide, but we found that no matter what time-interval was selected for comparison, the above qualitative picture was seen. Increases in mesenteric plasma alanine concentration were frequently observed, but similar increases also occurred in jugular venous plasma. Table 2 , compiled from results of a single experiment with Gly-L-Pro, illustrates this phenomenon and contrasts jugular plasma concentrations with those of mesenteric plasma.
Relationship between intraluminal and plasma concentrations
Mesenteric plasma concentrations of peptide and amino acids, after injection of different concentrations of peptide into the gut lumen, were studied using Gly-Gly. We found considerable individual variation in values obtained in separate experiments 15 min after injection of Gly-Gly in concentrations ranging from 20 to 100 mmol/l (Fig 3) . With the lowest concentraConcn.of peptide Wcted (pLmol/rnl)
FIG. 3. Effect of different concentrations of Gly-Gly injected intraluminally on mesentefic plasma
concentration of glycine and Gly-Gly. The ordinates represent increases in plasma concentration from original value (pmol/ml) and the abscissae indicate the intraluminal concentration (pmol/ml). Each value of the histograms represents a separate experiment, being obtained from a sample collected 15 min after intraluminal injection of 1.5 ml of peptide in NaCl(l50 mmol/l).
tion, plasma values were approximately 0.2 pmol/ml of plasma. With 50 mmol/l they ranged between 0.2 and 1.6 and with 100 mmol/l between 0.3 and 2.0 pmol/ml. It appears therefore that the plasma concentrations of Gly-Gly are related to the concentration of peptide introduced into the lumen. Similar remarks apply to the amino acid glycine (Fig. 3) .
D I S C U S S I O N
We have been able to show that six dipeptides containing the amino acids p-alanine, glycine, histidine, phenylalanine and proline are absorbed intact by the small intestine of the rat when injected intraluminally in high concentrations (20-100 pmol/ml). We demonstrated absorption directly, detecting the various peptides in the mesenteric venous blood by ion-exchange chromatography. Previous workers have obtained evidence for the absorption intact of some of the peptides we have studied. Peters & MacMahon (1970) and Adibi (1971) have described the absorption of intact Gly-Gly into the blood in vivo, although Agar, Hird & Sidhu (1953) showed passage of intact Gly-Gly across the intestine in vitro. Rubino, Field & Shwachman (1971) have obtained data which were highly suggestive of intact absorption of Gly-L-Pro. In human experiments Perry et al. (1967) reported that carnosine could pass intact from the intestinal lumen into the blood and Navab & Asatoor (1970) have obtained data suggesting mucosal uptake of intact carnosine in a case of Hartnup disease. Previously, Craft, Geddes, Hyde, Wise & Matthews (1968) showed that intact absorption of di-and tri-glycine probably occurred before intracellular hydrolysis. However, this appears to be the first unequivocal demonstration of the absorption of intact L-Pro-Gly, Gly-L-Phe and Gly-D-Phe.
It is of interest to compare our results relating to increased plasma amino acid concentration after intraluminal peptide injection, with data obtained by Burston et al. (1972) on peptide and amino acid uptake into rings of everted rat ileum in vitro. In both cases there was no obvious relationship between the rate of peptide hydrolysis by intact rings or tissue homogenates and the extent of uptake ofthe constituent amino acids. These results were not surprising, because there are many factors which will affect amino acid concentrations. Steady-state conditions do not exist in the situations either in vivo or in vitro. There are various processes which will influence the concentrations of amino acids in any particular location. Thus in our experiments in vivo we do not know the amino acid concentrations within the cell, nor the extent of efflux of amino acids into the intestinal lumen.
The absence of any differences in plasma concentration of C-and N-terminal amino acid components of the peptides we have studied provides additional support for the idea that intact dipeptides are removed from the intestinal lumen before significant hydrolysis occurs. This hypothesis, first put forward for Gly-Gly by Newey & Smyth (1959), would lead one to expect equal concentrations of C-and N-terminal amino acids of the peptide on the serosal side of the intestine.
Our observations of increased plasma alanine concentration are in agreement with those of other workers, since Craft et al. (1968) and Peters & MacMahon (1970) have reported similar results after the administration of glycine and peptides containing glycine. The mechanism of these increases has not been established. As too little is known of the interactions between amino acids in blood and tissues it is not possible for us to comment further on this phenomenon.
One question arising as a result of our observations concerns the relevance of the results in relation to peptide concentrations likely to occur in the gastrointestinal tract after normal food intake. First, we found that the frequency of detection of unhydrolysed peptide was inversely related to the rate of peptide hydrolysis. Although our hydrolysis system was in all probability quite different from conditions in the intact animal, relative comparisons of the various peptide hydrolysis rates appear valid. Thus it is reasonable to suggest that absorption of intact peptide into the blood may occur under physiological conditions in the case of those dipeptides where the rate of hydrolysis is very slow.
Secondly, the experiments with Gly-Gly indicated that absorption of intact peptide and glycine was approximately proportional to intraluminal concentration of dipeptide, although the lowest concentration studied (20 ,umol/ml) is higher than any likely to occur under physiological conditions.
Despite the high intraluminal concentrations used in all our studies, our experimental procedure probably approximates fairly closely to physiological conditions. Whether or not a significant proportion of protein digestion products will enter the blood as peptides under normal conditions, and the relevance of such observations to human physiology, can only be determined by further investigation in vivo.
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